| PIAS1 |
PIAS1, DDXBP1: E3 SUMO-protein ligase PIAS1 |
SKI |
SKI: Ski oncogene |
0.995 |
Evidence |
|
| EIF4G3 |
EIF4G3: Eukaryotic translation initiation factor 4 gamma 3 |
SKI |
SKI: Ski oncogene |
0.995 |
Evidence |
|
| CLIC2 |
CLIC2: Chloride intracellular channel protein 2 |
CKM |
CKM, CKMM: Creatine kinase M-type |
0.995 |
Evidence |
|
| KPNA5 |
KPNA5: Importin subunit alpha-6 |
CDK2 |
CDK2: Cell division protein kinase 2 |
0.995 |
Evidence |
|
| PRRX2 |
PRRX2, PMX2, PRX2: Paired mesoderm homeobox protein 2 |
FAM46C |
IPI00646224 |
0.993 |
Evidence |
|
| PFKP |
PFKP, PFKF: 6-phosphofructokinase type C |
ATP6V0A1 |
IPI00465178 |
0.993 |
Evidence |
|
| PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
SLC39A1 |
SLC39A1, IRT1, CGI-08, ZIP1, CGI-71, ZIRTL: Zinc transporter ZIP1 |
0.993 |
Evidence |
|
| SAG |
SAG: S-arrestin |
SLC9A3 |
SLC9A3, NHE3: Sodium/hydrogen exchanger 3 |
0.993 |
Evidence |
|
| PPM1B |
PPM1B, PP2CB: Protein phosphatase 1B |
DVL3 |
DVL3, KIAA0208: Segment polarity protein dishevelled homolog DVL-3 |
0.993 |
Evidence |
|
| PPM1B |
PPM1B, PP2CB: Protein phosphatase 1B |
GRM2 |
GRM2, GPRC1B, MGLUR2: Metabotropic glutamate receptor 2 precursor |
0.993 |
Evidence |
|
| YPEL1 |
YPEL1, FKSG3: Protein yippee-like 1 |
ARIH2 |
ARIH2, ARI2, HT005, TRIAD1: Protein ariadne-2 homolog |
0.993 |
Evidence |
|
| GNG7 |
GNG7, GNGT7: Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 p |
AMOT |
IPI00644547 |
0.993 |
Evidence |
|
| SGTA |
SGTA, SGT: Small glutamine-rich tetratricopeptide repeat-containing protein A |
RPP25 |
RPP25: Ribonuclease P protein subunit p25 |
0.993 |
Evidence |
|
| GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
PCAF |
PCAF: Histone acetyltransferase PCAF |
0.99 |
Evidence |
|
| PIK3CB |
PIK3CB, PIK3C1: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit |
PDLIM5 |
PDLIM5, ENH: PDZ and LIM domain protein 5 |
0.99 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
PDLIM5 |
PDLIM5, ENH: PDZ and LIM domain protein 5 |
0.99 |
Evidence |
|
| CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
AVPR1B |
AVPR1B, AVPR3, VPR3: Vasopressin V1b receptor |
0.99 |
Evidence |
|
| FAT2 |
FAT2, CDHF8, KIAA0811, MEGF1: Protocadherin Fat 2 precursor |
AP2B1 |
AP2B1: Uncharacterized protein AP2B1 |
0.99 |
Evidence |
|
| DARC |
DARC, FY, GPD: Duffy antigen/chemokine receptor |
CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
0.99 |
Evidence |
|
| OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
0.99 |
Evidence |
|
| GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
AVPR1B |
AVPR1B, AVPR3, VPR3: Vasopressin V1b receptor |
0.99 |
Evidence |
|
| AVPR1A |
AVPR1A, AVPR1: Vasopressin V1a receptor |
CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
0.99 |
Evidence |
|
| AVPR1A |
AVPR1A, AVPR1: Vasopressin V1a receptor |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.99 |
Evidence |
|
| AVPR1A |
AVPR1A, AVPR1: Vasopressin V1a receptor |
GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
0.99 |
Evidence |
|
| OXTR |
OXTR: Oxytocin receptor |
CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
0.99 |
Evidence |
|